No Data
No Data
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating
Tyra Biosciences to Present at Upcoming Investor Conferences
One Tyra Biosciences Insider Raised Stake By 284% In Previous Year
Tyra Biosciences Appoints Adele M. Gulfo to Board
Express News | Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors
Private Equity Firms Account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) Ownership, While Institutions Account for 33%